pd168393 has been researched along with Colonic Neoplasms in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SJ | 1 |
| Noh, TH | 1 |
| Son, S | 1 |
| Kim, DH | 1 |
| Kim, W | 1 |
| Lee, Y | 1 |
| Choo, J | 1 |
| Heo, G | 1 |
| Kim, MJ | 1 |
| Chung, HY | 1 |
| Jung, Y | 1 |
| Jung, JH | 1 |
| Moon, HR | 1 |
| Im, E | 1 |
1 other study available for pd168393 and Colonic Neoplasms
| Article | Year |
|---|---|
Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
Topics: Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; ErbB Receptors; | 2018 |